Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

232 Views

130. Adult Vaccines: Friday, 12:15 - 1:30 p.m.

Poster Session: Adult Vaccines

(1159) A Phase 2 Drug-Vaccine Interaction Study of AV7909 and Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics

Friday, October 13, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

GA

Gideon Akintunde, Director Clinical Development

Emergent Biosolutions
Gaithersburg, Maryland, United States
BD

Bojan Drobic, Director Clinical Development

Sr. Director Clinical Research
Emergent Biosolutions
Gaithersburg, Maryland, United States
LB

Lisa Bedell, Director Biostatistic

Director Biostatistic
Emergent Biosolutions
Gaithersburg, Maryland, United States
LG

Lu Gan, Director Biostatistic

Director Biostatistic
Emergent Biosolutions
Gaithersburg, Maryland, United States
JK

Julia Kim, Scientist Clinical Development

Scientist Clinical Development
Emergent Biosolutions
Gaithersburg, Maryland, United States
MB

Marinda Beah, Manager Clinical Trials Development

Manager Clinical Trials Development
Emergent Biosolutions
Gaithersburg, Maryland, United States

Presenting Author(s)

IG

Isaac Ghinai, Medical Director (he/him/his)

Medical Director
Emergent Biosolutions
Gaithersburg, Maryland, United States

Co-Author(s)

SB

Santiago Barona Collado, Medical Director

Medical Director
Emergent Biosolutions
Valencia, Comunidad Valenciana, Spain